KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $24,641,886 | +567.4% | 77,855 | +256.5% | 11.57% | +430.1% |
| Q3 2023 | $3,692,418 | -22.0% | 21,837 | 0.0% | 2.18% | -26.5% |
| Q2 2023 | $4,735,353 | +19.4% | 21,837 | 0.0% | 2.97% | +8.3% |
| Q1 2023 | $3,966,473 | -7.6% | 21,837 | 0.0% | 2.74% | -21.4% |
| Q4 2022 | $4,290,971 | +31.8% | 21,837 | +50.8% | 3.49% | +41.8% |
| Q3 2022 | $3,256,000 | +3.0% | 14,476 | -42.0% | 2.46% | +9.9% |
| Q2 2022 | $3,160,000 | -0.2% | 24,976 | 0.0% | 2.24% | +41.2% |
| Q1 2022 | $3,167,000 | -3.2% | 24,976 | 0.0% | 1.58% | +12.4% |
| Q4 2021 | $3,272,000 | +48.5% | 24,976 | +38.7% | 1.41% | +49.3% |
| Q3 2021 | $2,203,000 | +48.6% | 18,006 | +38.4% | 0.94% | +15.0% |
| Q2 2021 | $1,483,000 | -5.2% | 13,006 | 0.0% | 0.82% | -25.3% |
| Q1 2021 | $1,564,000 | +18.4% | 13,006 | 0.0% | 1.10% | -5.1% |
| Q4 2020 | $1,321,000 | +241.3% | 13,006 | +159.8% | 1.16% | +208.0% |
| Q3 2020 | $387,000 | – | 5,006 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |